• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童炎症性肠病结肠黏膜中巨细胞病毒的检测:炎症性肠病。

Detection of Cytomegalovirus in Colonic Mucosa of Children With Inflammatory Bowel Disease: Inflammatory Bowel Disease.

机构信息

Section of Pediatric Gastroenterology, Department of Pediatrics and Child Health.

Department of Pathology.

出版信息

J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):221-224. doi: 10.1097/MPG.0000000000001976.

DOI:10.1097/MPG.0000000000001976
PMID:29601437
Abstract

OBJECTIVES

Although it has been recommended to perform sigmoidoscopy to screen for cytomegalovirus (CMV) reactivation in acute severe colitis, the frequency of CMV reactivation in children with inflammatory bowel disease (IBD) is unknown. The aim of this study was to determine the frequency and management of CMV detection in colonic mucosa of children with IBD.

METHODS

In a retrospective study, consecutive IBD patients, <17 years old, with moderate to severe colitis who had sigmoid biopsy specimens evaluated for CMV by hematoxylin and eosin (H&E) staining, immunohistochemistry (IHC), and polymerase chain reaction (PCR) were included.

RESULTS

A total of 90 sigmoid biopsies were collected from 67 patient encounters from 58 patients with colitis: 61 patient encounters (91%) with UC/IBD-U including biopsy samples from colectomy specimens of eight patients who had colectomy during the study period. Medication exposure included corticosteroids for 40 (69%) patients, and immunosuppressive agents for 31 (53.4%) patients. Four of 61 patient encounters (6.6%) with UC/IBD-U, two with corticosteroid refractory disease, had positive biopsies for CMV by PCR but negative H&E and IHC. They responded to escalated medical therapy, without needing anti-viral therapy, and none required colectomy over a median duration of follow up of 1.1 year (IQR 1-1.6).

CONCLUSIONS

CMV presence is uncommon in colonic mucosa of children with IBD. Studies examining the underlying sero-prevalence of CMV and its role of reactivation of colitis are required to determine if the current recommendation for routine sigmoidoscopy to exclude CMV infection in corticosteroid-refractory acute severe colitis is justified.

摘要

目的

虽然已经建议对急性重度结肠炎患者进行乙状结肠镜检查以筛查巨细胞病毒(CMV)再激活,但儿童炎症性肠病(IBD)患者 CMV 再激活的频率尚不清楚。本研究旨在确定 IBD 儿童结肠黏膜中 CMV 检测的频率和管理方法。

方法

在一项回顾性研究中,纳入了接受中度至重度结肠炎治疗且行乙状结肠镜活检的连续 IBD 患者,这些患者的乙状结肠镜活检标本通过苏木精和伊红(H&E)染色、免疫组织化学(IHC)和聚合酶链反应(PCR)进行 CMV 检测。

结果

从 58 例结肠炎患者的 67 次就诊中收集了 90 份乙状结肠镜活检标本:61 次就诊(91%)为 UC/IBD-U,包括 8 例在此期间接受结肠切除术患者的结肠切除标本中的活检样本。药物暴露包括 40 例(69%)患者接受皮质类固醇治疗,31 例(53.4%)患者接受免疫抑制剂治疗。4 例(6.6%)UC/IBD-U 患者,2 例为皮质类固醇难治性疾病,PCR 检测到 CMV 阳性活检,但 H&E 和 IHC 检测为阴性。他们对强化药物治疗有反应,无需抗病毒治疗,在中位数为 1.1 年(IQR 1-1.6)的随访期间,没有患者需要结肠切除术。

结论

CMV 在 IBD 儿童的结肠黏膜中并不常见。需要研究 CMV 的潜在血清流行率及其在皮质类固醇难治性急性重度结肠炎中引发结肠炎的作用,以确定目前建议对皮质类固醇难治性急性重度结肠炎患者进行常规乙状结肠镜检查以排除 CMV 感染是否合理。

相似文献

1
Detection of Cytomegalovirus in Colonic Mucosa of Children With Inflammatory Bowel Disease: Inflammatory Bowel Disease.儿童炎症性肠病结肠黏膜中巨细胞病毒的检测:炎症性肠病。
J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):221-224. doi: 10.1097/MPG.0000000000001976.
2
Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases.在炎症性肠病恶化期间,巨细胞病毒感染的频率较低。
J Med Virol. 2010 Oct;82(10):1694-700. doi: 10.1002/jmv.21877.
3
Cytomegalovirus Infection in Ulcerative Colitis is Related to Severe Inflammation and a High Count of Cytomegalovirus-positive Cells in Biopsy Is a Risk Factor for Colectomy.溃疡性结肠炎中的巨细胞病毒感染与严重炎症相关,活检中巨细胞病毒阳性细胞数量高是结肠切除术的危险因素。
J Crohns Colitis. 2016 Oct;10(10):1205-11. doi: 10.1093/ecco-jcc/jjw071. Epub 2016 Mar 12.
4
Review article: cytomegalovirus and inflammatory bowel disease.综述文章:巨细胞病毒与炎症性肠病
Aliment Pharmacol Ther. 2015 Apr;41(8):725-33. doi: 10.1111/apt.13124. Epub 2015 Feb 16.
5
Cytomegalovirus in pediatric inflammatory bowel disease patients with acute severe colitis.巨细胞病毒在小儿炎症性肠病合并急性暴发性结肠炎患儿中的作用
Clin Res Hepatol Gastroenterol. 2021 Nov;45(6):101625. doi: 10.1016/j.clinre.2021.101625. Epub 2021 Mar 1.
6
Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.炎症性肠病中的人巨细胞病毒和爱泼斯坦-巴尔病毒感染:需要测量黏膜病毒载量
World J Gastroenterol. 2015 Feb 14;21(6):1915-26. doi: 10.3748/wjg.v21.i6.1915.
7
The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China.华中武汉地区炎症性肠病患者中巨细胞病毒感染的流行情况及危险因素。
Virol J. 2013 Feb 1;10:43. doi: 10.1186/1743-422X-10-43.
8
Colonic cytomegalovirus DNA detection by polymerase chain reaction does not influence outcomes in inflammatory bowel disease and immunosuppressed cohorts.聚合酶链反应检测结肠巨细胞病毒 DNA 并不影响炎症性肠病和免疫抑制队列的结局。
Intern Med J. 2024 Feb;54(2):283-289. doi: 10.1111/imj.16176. Epub 2023 Jul 18.
9
Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection.类固醇难治性炎症性肠病是巨细胞病毒感染的一个风险因素。
Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):858-65.
10
Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.通过黏膜聚合酶链反应检测溃疡性结肠炎中的结肠巨细胞病毒及抗病毒治疗
PLoS One. 2017 Sep 8;12(9):e0183951. doi: 10.1371/journal.pone.0183951. eCollection 2017.

引用本文的文献

1
Involvement of HHV-4 (Epstein-Barr Virus) and HHV-5 (Cytomegalovirus) in Inflammatory Bowel Disease and Colorectal Cancer: A Meta-Analysis.人疱疹病毒4型(爱泼斯坦-巴尔病毒)和人疱疹病毒5型(巨细胞病毒)与炎症性肠病和结直肠癌的关系:一项荟萃分析
Cancers (Basel). 2022 Oct 17;14(20):5085. doi: 10.3390/cancers14205085.
2
Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC).巨细胞病毒与炎症性肠病(IBD),特别关注与溃疡性结肠炎(UC)的关联。
Microorganisms. 2020 Jul 20;8(7):1078. doi: 10.3390/microorganisms8071078.
3
Quality improvement in healthcare for patients with inflammatory bowel disease.
炎症性肠病患者医疗保健的质量改进。
Transl Pediatr. 2019 Jan;8(1):77-82. doi: 10.21037/tp.2019.01.02.